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Cutaneous erythema and edema can be
elicited in the rat by a variety of substances.
Some, like dextran or ovomucoid, induce a
reaction localized at the extremities, tbe snout,
and the genital area while others, like com-
pound 48/80 or polymyxin, affect rather evenly
the entire skin surface. A feature common to
all these agents is that they cause mast cell
degranulation in hyperemie areas. Histamine
and, in the rat, serotonin are usually released
from degranulating mast cells (1—3). Com-
pound 48/80 is well known to induce a decrease
in mast cell population as well as in the con-
tent of histamine (2, 4) and of serotonin
(5, 6) in the tissues of the rat.
The object of this communication is to de-
scribe a generalized erythema induced by ad-
ministration of certain iodine salts, to study
the behavior of mast cells under the influence
of these iodides and to determine whether or
not the presence of mast cells is necessary for
the erythematous reaction to appear. The re-
sults of these experiments have been described
in a preliminary note (7).
MATERIALS AND METHODS
Two hundred and fifty female Sprague-Dawley
rats with a mean initial body weight of 115 gm
(range: 109 to 119 gm) were divided into 25
equal groups and treated as shown in Table I, IT,
III and IV. Throughout the experiments the rats
were maintained on Purina Laboratory Chow(Purina Co. of Canada) and tap water. The
iodides (NaT, KT, NH4T, Fisher Scientific Co.,
Montreal, Canada and MgL 8H20, Amend Drug
and Chemical Co., New York) were administered
twice daily. The degree of erythema was assessed
semiquantitatively on the basis of an arbitrary
scale of 0 to 3, in which 0 no erythema, 1 = just
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detectable, 2 = moderate and 3 maximal. The
means of these readings together with the per-
centage of incidence of erythema are shown in
Tables I and TI. The experiments were terminated
by killing the survivors with chloroform. Portions
of tongue, abdominal skin and lower lip were
fixed in a mixture of alcohol, formahn and acetic
acid for maximal retention of metachromatie
material (8), embedded in paraffin, cut at 10 e
and stained with dilute Wright for easy identifica-
tion of mast cells whose granules become deep
blue. The cells were counted with the help of an
ocular grid, in the tongue and in the dermis of
abdominal skin and cutaneous aspect of lower
lip, at a magnification of 400, which produced a
field of 0.067 mm2.
In the first experiment, the individual dose of
all iodides (the amount indicated in Table 1) was
given in 2 ml of water, by gavage. The animals
were killed on the twelfth day, and portions of
tongue, abdominal skin and lower lip were fixed
for mast cell study. The intensity and incidence of
erythema were recorded daily. The means of the
readings for three representative days can be
found in Table I.
The second experiment (Table TI) was under-
taken to find out if erythema would appear after
subcutaneous or intraperitoneal injections of so-
dium iodide. Since preliminary experiments had
shown that stepwise increase of concentration of
iodide enhances the intensity of erythema, the ani-
mals were given sodium iodide at the dosage of
0.5 mM for the first four days and of 1 mM on
the fifth and subsequent days. Animals of group
2 received the salt by gavage as in the previous
experiment, while those of group 3 received it
subcutaneously in the back in 0.5 ml of water and
those of group 4 intraperitoneally in 1 ml of
water. In order to determine if capillary leakage
of dye would occur during a period of maximal
hyperemia, five controls (group 1) and five iodide-
treated rats (group 2) were injected on the seventh
day of the experiment with 1.6 mg of Evans blue
in 1 ml of water in the jugular vein under light
ether anesthesia (9). Twelve hours later all the
injected animals were killed and shaved. The re-
maining hair was removed with a depilator. The
other rats were killed on the twelfth day and the
usual tissues fixed for histological study.
The aim of the third experiment was to estab-
lish if chronic treatment with various iodides
would alter the mast cell count of tongue, abdom-
inal skin and lower lip. All the iodides were ad-
ministered in 2 ml of water by gavage in a similar
dosage: 0.5 mM for the first twenty days, 0.75
mM from the twenty-first to the thirtieth day
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RESULTS
Erythema starts on the second day of treat-
ment with iodine salts. The reaction begins
with reddening of the base of the ears. It
then spreads to the rest of the ears and
gradually involves the whole skin. The in-
tensity and duration of erythema are dose
dependent (Table I). The only exception was
magnesium iodide which induced a weak re-
action with as little as 0.125 mM and a more
intense erythema with 0.5 mM than with
0.75 mM. Since all the animals were given
equimoleeular amounts of the various iodides,
even of the hydrated magnesium iodide, it is
possible that the peculiar effect of the latter
and its toxicity (all the rats of group 9 were
dead by the seventh day) is related to its con-
taining two iodine atoms in the molecule.
Erythema reached a maximum by the fourth
day and then gradully diminished. It was
finished by the twelfth day except in animals
receiving 0.5 mM of sodium iodide (group
2), potassium iodide (group 5), or ammonium
iodide (group 11).
As can be seen in Table II, stepwise increase
in concentration of sodium iodide displaced
the peak of erythema to the seventh day. In
all eases the reaction was finished by the
twelfth day. At the peak of erythema, a slight
and transient edema of the snout and dorsal
surface of the paws was present. It ordinarily
appeared on the seventh day and was gone
the following day. The edema of the ears was
more marked and lasted as long as the erythema
persisted. The intravenous injection of Evans
blue in the animals of group 2 was followed
by an intense coloring of the edematous areas
and a less marked bluing of the entire skin
(Fig. 1). Evans blue at this dosage produced
only a faint light gray coloration of the skin
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Fro. 1. Rats injected in jugular vein with Evans blue on seventh day of experiment.
The control animal (left) shows a uniform light gray staining of the skin. Darker spots
over ealvariurn correspond to red capillary bed showing through skin. The sodium iodide
treated rat (right) shows intense bluing of head, ears, paws, and less marked coloring
of whole skin.
and 1 mM from the thirty-first to the fortieth
day. The results of the mast cell counts together
with their standard errors are listed in Table III.
The fourth experiment was done to ascertain if
chronic pre-treatment with ascending doses of
compound 48/80 would alter the development of
erythema upon subsequent administration of so-
dium iodide. The animals of groups 3 and 4(Table IV) were treated for 11 days with in-
creasing doses of 48/80 in 0.2 ml of water ad-
ministered subcutaneously twice daily starting
with 50 tg on the first day with regular increases
up to 900 g on the ninth day. This last dose was
then injected twice daily by the same route for
the last two days. Starting on the twelfth day, the
animals of group 2 and 4 received sodium iodide
by gavage at the dose of 1 mM in 2 ml of water.
The degree of erythema was assessed daily. The
means of these readings with standard error and
the percentage of incidence of erythema are shown
in Table IV.
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TABLE I
Induct ion of erythema by various iodine salts
Group Treatment mM
Erythem a
4th D 7th D 12th D
Intensity
(Scale 0—3)
Incidence
%
Intensity
(Scale 0—3)
Incidence
%
Intensity
(Scale 0—3)
Incidence
%
1
2
3
4
5
6
7
8
9
10
11
12
NaT:
XI:
Mg12.8H20:
NH4I:
0.125
0.5
0.75
0.125
0.5
0.75
0.125
0.5
0.75
0.125
0.5
0.75
0
1.2
2.1
0
1.6
1.9
0.2
2.0
1.3
0
1.2
2.0
0
70
100
0
90
100
20
100
100
0
60
100
0
1.0
0.8
0
1.0
0.4
0
0.4
—
0
1.3
1.8
0
70
60
0
70
30
0
40
—
0
100
100
0
0.1
0
0
0.1
0
0
0
—
0
0.7
0
0
10
0
0
10
0
0
0
—
0
70
0
TABLE II
Effect of route of administration of iodide on erythema
Group Treatment*
Erythema
4th D 7th D 12th D
Intensity
(Scale 0—3)
Incidence
%
Intensity
(Scale 0—3)
Incidence
% Intensity(Scale 0—3)
Incidence
%
1
2
3
4
Control
Nal, P.O.
NaT, S.C.
NaT, I.P.
0
0.7
0.8
1.0
0
70
80
80
0
2.6
2.2
2.0
0
100
100
100
0
0
0
0
0
0
0
0
* Sodium iodide was given twice a day at the dosage of 0.5 mM from the first to the fourth day of
the experiment and of 1 mM thereafter. The salt was administered by gavage (p.o.), subcutaneously
(s.c.) or intraperitoneally (i.p.).
of the control rats (group 1). Dye leakage
through skin capillaries after treatment with
erythema-producing agents is well known (5).
Microscopic examination of tongue, lower
lip and abdominal skin after twelve days of
treatment with increasing doses of sodium
iodide (Table II, groups 2, 3, 4) revealed swell-
ing, vacuolation of the cytoplasm and degranu-
latiori of mast cells (Fig. 2), regardless of the
route of administration. The extent and sever-
ity of mast cell damage were not as great
after treatment with 0.75 mM of so-
dium iodide (Table I, group 3) and gradually
decreased with lesser doses so that 0.125 mM
(Table I, group 1) induced only minimal
changes. The effect of other iodides after twelve
days of treatment was similar: the mast cell
damage was generally proportional to the dose
of salt used.
After twenty days of treatment with sodium
iodide (Table III) erythema was no longer
present. The subsequent increases in dosage,
to 0.75 mM and finally to 1 mM, were not
followed by reappearance of erythema although
the same doses of iodide, given to untreated
rats of similar weight, invariably produced
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FIG. 2. Top left: Section of tongue of normal rat: Mast cells appear as dark, well de-
limited dots on a light background. Top right: Section of tongue of iodide-treated rat(sodium iodide by gavage twice a day for 12 days; ½ mM from the first to the fourth
day and 1 mM thereafter). Mast cells are hazy because of peripheral dispersion of granules
and the presence of fine vacuoles in their cytoplasm. Bottom left: Section of lower lip of
iodide-treated rat: Mast cells are swollen and contain some vacuoles. Bottom right: Section
of abdominal skin: Mast cells in dermis are swollen. Some are surrounded by granules.
Dilute Wright X 400.
crythema (10). Thus chronic treatment with
relatively low doses of iodide precludes the
occurrence of erythema upon exposure of
the animals to higher concentration of the salt.
Forty days of treatment with increasing
doses of various iodides decreased the dcrmal
mast cell population of abdominal skin by
42% to 65% (Table III), depending on the salt
used. The diminution of the number of mast
cells in the dermis of the lower lip and in
the tongue was not as important, varying be-
tween 39% and 43% in the former and be-
tween 24% and 46% in the latter. Of the
remaining mast cells, only a few were dc-
granulated, and most assumed a normal ap-
pearance.
The rats injected with ascending doses of
48/SO (Table IV, groups 3 and 4) showed
erythema and edema of the extremities. These
effects, generally attributed to liberation of
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TABLE III
Effect of chronic treatment with iodine salts on the mast cell population of some tissues
Tissue Treatment5 Number at fields Tutalnsmlr ot Average/field
Tongue Control (7)t
NaT (8)
RI (4)
MgIs8H2O
NH4I (3)
(4)
1169
1339
833
925
600
7723
4950
3618
4677
2853
6.6 0.80
3.6 0.20
4.3 0.18
5.0 0.18
4.7 0.10
Abdominal skin Control (7)
NaT (8)
XI (5)
MgJs8H20
NH4T (3)
(4)
293
283
201
161
140
1975
1099
564
394
421
6.7 0.72
3.9 0.31
2.8 0.25
2.4 0.33
3.0 0.17
Lower lip Control (7)
NaT (7)
RI(S)
MgIs8HsO
NH5I (4)
(4)
257
320
200
167
164
3217
2431
1547
1204
1266
12.5 0.96
7.6 0.45
7.7 0.55
7.2 0.70
7.7 0.14
* The iodine salts were given twice a day at the following doses: 0.5 mM for the first twenty days,
0.75 mM from the twenty first to the thirtieth day and 1 mM from the thirty first to the fortieth day.
t Parentheses enclose the number of animals used for mast cell count.
TABLE IV
Effect of pretreatment with 48/80 on
iodide-induced erythema
Erythema
Gruup Pretreat-ment*
Treat-
mentt Intensity
(Scale 0—3)
Incidence
%
1 None None 0 0
2 None NaT 2.5 0.18 100
3 48/80 None 0 0
4 48/80 NaT 0 0
* Compound 48/80 was given from the first to
the eleventh day of the experiment.
t Sodium iodide was administered at the dosage
of 1 mM starting on the twelfth day of the experi-
ment. Reading of erythema was done on the
seventeenth day.
endogenous vasoactive amines, gradually de-
creased so that hardly any visible Sign of their
liberation could be detected even after the
last large doses of 48/80. All animals of group
2 (Table IV) that were treated with sodium
iodide developed a generalized erythema which
reached a maximum on the seventeenth day of
the experiment and gradually decreased there-
after. In animals that were pre-treated with
48/80 (group 4), subsequent administration of
sodium iodide did not produce erythema at any
time.
nrscussloN
Since the erythema induced by administra-
tion of various iodides is accompanied by
mast cell damage and eventually by a decrease
in the mast cell population of tongue, abdomi-
nal skin and lower lip, it is possible that
peripheral vasodilatation is related to the re-
lease of vasoactive amines from mast cells.
The absence of erythema in the 48/SO-treated
rats gives support to this hypothesis. Decrease
of the mast cell population and of the his-
tamine and serotonin content of tissues by
48/SO would prevent the occurrence of erythema
upon subsequent treatment with sodium iodide
by removing the cause of the peripheral
effect of the iodide. The absence of erythcma
in rats chronically treated with sodium iodide
upon exposure to a higher concentration of
the iodide could be interpreted in the same
manner.
Several mechanisms whereby iodides could
influence mast cells arc possible. Todides could
primarily influence blood vessels since it has
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long been known that topical application of
iodine on a mucous membrane is followed by
vasodilatation (11). Similarly, administration
of iodine to the whole animal or limb and
organ perfusion allegedly induces a variable
degree of vasodilatation depending on the
species used and on various other factors
12). If this is correct, mast cell degranula-
tion and possibly subsequent histamine or
serotonin release would be secondary phenom-
ena related to osmotic and other environ-
mental changes in connective tissue. The pas-
sive breakdown of mast cells as a result of
vasodilatation and edema is well documented
(13, 14). This hypothesis is difficult to recon-
cile with the fact that previous chronic
treatment with 48/80 or iodide prevents the
occurrence of erythema upon subsequent admin-
istration of iodide. Another possibility arises
from the fact that an anaphylactie shock has
been produced in the guinea pig by injection
of a mixture of iodine and guinea pig serum
(15). Also the occurrence of periarteritis
nodosa as well as of arthralgia and cosinophilia
in a patient suffering from iodine intoxication
has led Rich to postulate hypersensitivity as
the cause of these phenomena (16). It is thus
possible that erythema and mast cell degranu-
lation, following iodine intoxication in the
rat, could have a similar basis. A third pos-
sibility stems from radioautographic studies
which showed that the injection to rats of
carrier free sodium iodide" or sodium
iodide'25 produces a selective concentration of
radioactivity in mast cells of skin and muscle
even after thyroideetomy or treatment with
propylthiouraeil (17). The fact that no mast
cell damage was reported after injection of
tracer doses of iodide is in agreement with
our findings that even as high a dose as
0.125 mM of sodium iodide does not induce
erythema and produces only minimal mast
cell disruption. This observation, however,
raises the possibility that the breakdown of
mast cells in skin and tongue following ad-
ministration of large doses of iodidcs results
from the selective accumulation to toxic levels
of iodide in these cells. If this assumption is
correct, mast cell degranulation and erythema
are merely a special manifestation of iodine
toxicity and do not depend on hypersensitiv-
ity reactions or on primary vascular in-
volvement.
Iodine has been extensively used in clinical
medicine for such diverse ailments as coughs,
syphilis and thyrotoxicosis. It has been ad-
ministered to patients in radiological con-
trast substances, in proprietary asthma tablets,
in syrups, and in the form of Lugol's solution
or compound solution of iodine. The relatively
infrequent toxic reactions to iodine in man
are characterized by pruritus, maeulopapular
cutaneous erythema, pharyngeal erythema,
conjunctivitis, coryza, fever and cosinophilia
(16, 18—20). Since eosinophilia has been linked
with release of histamine (21), the possibility
arises that some of the effects of iodine in-
toxication in man, depend, at least partly,
on mast cell damage and liberation of hista-
mine.
5UMMARY
Administration of large doses of various
iodidcs to rats is followed by a generalized
crythema accompanied by mast cell degranula-
tion and eventually by decrease in the mast
cell population of various tissues. This reac-
tion is prevented by previous treatment with
48/80 or iodide.
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